Sernova Biotherapeutics Inc SVA.TO
As ofNov 13, 2026, 3:09 PM EST
- YTD
- -15.38%
- 1 year
- -21.43%
- Market cap
- 41.54M
- EPS (ttm)
- 0.01
- Shares out
- 325.32M
- P/E ratio
- 11.00
- Forward P/E
- -3.14
- YTD return
- -15.38%
- 1-year return
- -21.43%
- Volume
- 6.31K
- Avg volume
- 201.40K
- Open
- 0.11
- Previous close
- 0.105
- Day's range
- 0.11 – 0.11
- 52-week range
- 0.09 – 0.20
- Beta
- 1.32
5D +0.0050 (+4.55%)
Key statistics
- Enterprise value
- 70.40M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -11.50M
- Total cash
- 5.02M
- Total debt
- 592.23K
- Return on equity
- -726.29%
- Short % of float
- 0.00%
- 50-day average
- 0.2424
- 200-day average
- 0.3205
About Sernova Biotherapeutics Inc
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Canada
- Website
- sernova.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SVA.TO — it syncs with the Stock Master app.
